Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fukuda, Takahiro  [Clear All Filters]
2019
Kondo, E., Shimizu-Koresawa, R., Chihara, D., Mizuta, S., Izutsu, K., Ikegame, K., Uchida, N., Fukuda, T., Ichinohe, T., Atsuta, Y., et al. (2019). Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantatio.Br J Haematol.
Kawajiri, A., Kitano, S., Maeshima, A.Miyagi, Inamoto, Y., Tajima, K., Takemura, T., Tanaka, T., Ito, A., Okinaka, K., Kurosawa, S., et al. (2019). Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allo-HCT.Eur J Haematol.
Murata, M., Takenaka, K., Uchida, N., Ozawa, Y., Ohashi, K., Kim, S.-W., Ikegame, K., Kanda, Y., Kobayashi, H., Ishikawa, J., et al. (2019). Comparison of outcomes of allogeneic transplantation for primary myelofibrosis among hematopoietic stem cell source groups.Biol Blood Marrow Transplant.
Konuma, T., Kondo, T., Mizuno, S., Doki, N., Aoki, J., Fukuda, T., Tanaka, M., Sawa, M., Katayama, Y., Uchida, N., et al. (2019). Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.Biol Blood Marrow Transplant.
Takano, K., Ogata, M., Satou, T., Miyazaki, Y., Otsuka, E., Saito, N., Ueki, T., Kako, S., Fukuda, T., and Shirao, K. (2019). Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.Transpl Infect Dise13172.
Yamasaki, S., Nitta, H., Kondo, E., Uchida, N., Miyazaki, T., Ishiyama, K., Kiyota, M., Matsuoka, H., Ichinohe, T., Fukuda, T., et al. (2019). Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.Ann Hematol.
Yuda, S., Fuji, S., Onishi, A., Tanaka, T., Inamoto, Y., Kurosawa, S., Kim, S.-W., and Fukuda, T. (2019). Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Shinohara, A., Oshima, K., Fuji, S., Umeda, K., Kako, S., Kurokawa, M., Tsukada, N., Kasai, M., Kondo, T., Hashii, Y., et al. (2019). Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the JSHCT, transplant complications working group.Biol Blood Marrow Transplant.
Kondo, E., Ikeda, T., Izutsu, K., Chihara, D., Shimizu-Koresawa, R., Fujii, N., Sakai, T., Kondo, T., Kubo, K., Kato, Y., et al. (2019). High dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: Data from the Japan Society for Hematopoietic Cell Transplantation (JSHCT) registry.Biol Blood Marrow Transplant.
Kim, S.-W., Asakura, Y., Tajima, K., Iwai, T., Taji, H., Chou, T., Morishima, Y., Suzumiya, J., Sakamaki, H., Suzuki, R., et al. (2019). High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey.Int J Hematol.
Kawase, T., Tanaka, H., Kojima, H., Uchida, N., Ohashi, K., Fukuda, T., Ozawa, Y., Ikegame, K., Eto, T., Mori, T., et al. (2019). Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Morishima, Y., Morishima, S., Murata, M., Arima, N., Uchida, N., Sugio, Y., Takahashi, S., Matsuhashi, Y., Onizuka, M., Eto, T., et al. (2019). Impact of homozygous conserved extended HLA haplotype on single cord blood transplantation: Lessons for induced pluripotent stem cell banking and transplantation in allogeneic settings.Biol Blood Marrow Transplant.
Kako, S., Yamazaki, H., Ohashi, K., Ozawa, Y., Ota, S., Kanda, Y., Maeda, T., Kato, J., Ishiyama, K., Matsuoka, K.-I., et al. (2019). Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia.Biol Blood Marrow Transplant.
Yoshimitsu, M., Fuji, S., Utsunomiya, A., Nakano, N., Ito, A., Ito, Y., Miyamoto, T., Suehiro, Y., Kawakita, T., Moriuchi, Y., et al. (2019). Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors.Biol Blood Marrow Transplant.
Kawashima, N., Iida, M., Suzuki, R., Fukuda, T., Atsuta, Y., Hashii, Y., Inoue, M., Kobayashi, M., Yabe, H., Okada, K., et al. (2019). Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.Int J Hematol.
Fuji, S., Miyamura, K., Kanda, Y., Fukuda, T., Kobayashi, T., Ozawa, Y., Iwato, K., Uchida, N., Eto, T., Ashida, T., et al. (2019). Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.Int J Hematol.
Yanada, M., Konuma, T., Yamasaki, S., Kuwatsuka, Y., Masuko, M., Tanaka, M., Ozawa, Y., Toya, T., Fukuda, T., Ota, S., et al. (2019). Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant.
Arai, Y., Kondo, T., Fuse, K., Shibasaki, Y., Masuko, M., Sugita, J., Teshima, T., Uchida, N., Fukuda, T., Kakihana, K., et al. (2019). Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.Blood Adv3, 3626-3634.

Pages